The CDC is offering this grant to strengthen existing birth defects surveillance programs across states and territories. Its purpose is to enhance capacity to respond to emerging threats, identify and address health disparities, and ultimately improve health outcomes for mothers and babies. This will be achieved by improving surveillance capacity, leveraging electronic health records and interoperability, and ensuring high data quality for actionable insights. Birth defects are a leading cause of infant mortality and contribute significantly to healthcare costs in the U.S. This grant addresses the evolving needs in surveillance due to new health risks and technological advancements in data exchange. Key components include improving surveillance methods, developing EHR interoperability, and linking critical congenital heart defect screening data with surveillance systems.
Opportunity ID: 327986
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-DD21-2101 |
| Funding Opportunity Title: | Advancing Population-Based Surveillance of Birth Defects |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 10 |
| Assistance Listings: | 93.073 — Birth Defects and Developmental Disabilities – Prevention and Surveillance |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 05, 2020 |
| Last Updated Date: | Oct 05, 2020 |
| Original Closing Date for Applications: | Dec 08, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Dec 08, 2020 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | Jan 07, 2021 |
| Estimated Total Program Funding: | $3,100,000 |
| Award Ceiling: | $325,000 |
| Award Floor: | $30,000 |
Eligibility
| Eligible Applicants: | Small businesses County governments City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Special district governments Native American tribal organizations (other than Federally recognized tribal governments) State governments Private institutions of higher education Independent school districts Public housing authorities/Indian housing authorities For profit organizations other than small businesses Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility: | Eligible applicants must have the public health authority, legislative mandate or otherwise show legal access to the requisite data to conduct population-based birth defects surveillance. This authority allows unique and specific access to datasets from multiple data sources that are required to implement the activities outlined in this NOFO. Eligible applicants must document this authority in "Other Attachment Forms" with attachment name "Legal Authority". CDC will consider any application that does not include this required documentation as non- responsive and it will receive no further review. A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a Bona Fide Agent of a state government, a letter from the state government as documentation of the status is required and should be submitted under "Other Attachment Forms" with attachment name "Bona Fide Agent". If the Bona Fide Agent attachment does not specify legal authority, the applicant must include an attachment named "Legal Authority" in "Other Attachment Forms". Only one application per organization as determined by the organization’s Dun & Bradstreet number will be accepted for Component A. Applicants wishing to apply for optional Component B and/or Component C activities can include their Component B information and/or Component C information within their respective Component A application. |
Additional Information
| Agency Name: | Centers for Disease Control – NCBDDD |
| Description: | NOFO #CDC-RFA-DD21-2101 solicits non-research, cooperative agreement applications to strengthen the capacity of existing birth defects surveillance programs to respond to emerging threats to mothers and babies as a key component of preparedness, identify and address mechanisms contributing to health disparities, and improve the health outcomes among affected populations. This will be accomplished by 1) improving birth defects surveillance capacity, including leveraging electronic health records and interoperability capabilities to enhance surveillance of birth defects, 2) improving birth defects surveillance data quality, and 3) using the surveillance data to improve health outcomes of affected populations. Birth defects are a leading cause of infant mortality in the United States and contribute substantially to health care costs and life-long disabilities. They affect 1 in every 33 babies in the United States, account for more than 20% of all infant deaths, and contribute to $2.6 billion annually in hospital costs alone. The Birth Defects Prevention Act of 1998 directed CDC to carry out programs to collect data on birth defects and provide information to the public about the prevention of birth defects. Accurately tracking birth defects and analyzing the collected data is the first step in preventing birth defects. Although CDC has been funding surveillance of birth defects since the 1990s, changes in health risks to mothers and babies and changes in health care management require that birth defects surveillance programs evolve and develop new capacities. The Zika virus outbreak demonstrated the need for more timely surveillance of birth defects and underscored the importance of strengthening state and territorial health department capacity for responding to emerging threats. In addition, the emergence of electronic heath records and the capability to electronically exchange health data between systems (i.e. interoperability) using standards, such as HL7, for the exchange of clinical and administrative data is changing the way public health interacts with the medical community to support surveillance. This NOFO consists of 3 components. Component A (8-12 awards): improve surveillance capacity, improve surveillance data quality, improve knowledge of birth defects epidemiology, improve primary and secondary prevention, and evaluate the effectiveness of activities and disseminate findings. Component A applicants may, but are not required to apply for optional Component B and/or Component C activities. Component B (1-2 awards): develop interoperability capacity between birth defects surveillance systems and electronic heath records (EHRs). Component C (4-12 awards): link critical congenital heart defects (CCHDs) screening results with surveillance data. Recipients will report individual-level birth defects data and/or CCHD data to CDC. NCBDDD performance goal: Enhance the quality and utility of birth defects surveillance systems. |
| Link to Additional Information: | www.grants.gov |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Bill Paradies
wep2@cdc.gov Email:wep2@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 327986 Full Announcement-FULL_ANNOUNCEMENT -> CDC-RFA-DD21-2101.pdf
Packages
| Agency Contact Information: | Bill Paradies wep2@cdc.gov Email: wep2@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.073 | CDC-RFA-DD21-2101 | Advancing Population-Based Surveillance of Birth Defects | PKG00263691 | Oct 05, 2020 | Dec 08, 2020 | View |
Package 1
Mandatory forms
327986 SF424_2_1-2.1.pdf
327986 Project_AbstractSummary_2_0-2.0.pdf
327986 SFLLL_1_2-1.2.pdf
327986 SF424A-1.0.pdf
327986 BudgetNarrativeAttachments_1_2-1.2.pdf
327986 ProjectNarrativeAttachments_1_2-1.2.pdf
327986 HHS_CheckList_2_1-2.1.pdf
Optional forms
327986 OtherNarrativeAttachments_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
